论文部分内容阅读
采用随机对照的方法,进行协定方早熟 3号与早熟 2号合剂的随机对照研究。将 100例性早熟患儿,随机分入治疗组(早熟 3号,n=50)、对照组(早熟 2号,n=50),初诊进行体格检查(乳房Tanner分期、乳核直径),摄骨龄片,B超 (子宫、卵巢容积及卵泡大小 )检查,并进行中医辨证 8项指标积分,治疗 1月后随访乳核直径和中医辨证。结果:①两组治疗前后自身对照,疗程 1月与治疗前比较,乳核指数、中医辨证 8项积分均较前明显减少(P<0. 001);②两组之间初诊和疗程 1月时同期比较,乳核指数、中医辨证 8项积分无显著统计学差异 (P>0. 05)。结论:早熟 3号方与早熟 2号合剂治疗女童性早熟在缩小乳核和减轻阴虚火旺证候方面疗效相似。
A randomized controlled trial was conducted on a randomized controlled study of the combination of precocious puberty 3 and precocious puberty 2. 100 cases of precocious puberty children were randomly divided into treatment group (precocious puberty 3, n = 50) and control group (precocious puberty 2, n = 50). The physical examination (breast Tanner staging and core diameter) Bone age film, B ultrasound (uterine, ovarian volume and follicular size) examination, and TCM syndromes eight indicators integral, follow-up after 1 month of treatment of milk core diameter and TCM syndrome differentiation. Results: ①The two groups before and after treatment were compared with each other before treatment. The index of milk core index and syndrome of traditional Chinese medicine were significantly decreased in January and before treatment (P <0. 001) When compared with the same period, milk core index, TCM syndrome eight integral no significant difference (P> 0.05). Conclusion: The precocious No. 3 and precocious No. 2 combination therapy for girls precocious puberty in the reduction of milk nucleus and reduce Yin Huoxu syndrome efficacy similar.